{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-003240","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2026-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.461622+00:00","generated_at":"2026-05-15T07:00:58.960313+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ZEO ScientifiX selected as qualified team for XPRIZE Healthspan $101M competition semi-finals","bullets":["Advancing to semi-finals of XPRIZE Healthspan; aims to develop therapeutics restoring muscle, cognitive, and immune function by 10-20 years in persons aged 65-80.","Assembled multidisciplinary team: Dr. Shapiro (CMO), Elizabeth Parrish (BioViva), Dr. Andrews (telomere biology), Dr. Kennedy (Buck Institute), and others.","Focus on extracellular vesicle (exosome) therapeutics and next-generation delivery systems targeting aging and inflammation biology.","Company operates labs at Nova Southeastern University; recently appointed as A4M regenerative medicine educational partner."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-003240","json":"https://secwatch.observer/filing/0001829126-26-003240.json","markdown":"https://secwatch.observer/filing/0001829126-26-003240.md","text":"https://secwatch.observer/filing/0001829126-26-003240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912626003240/0001829126-26-003240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912626003240/zeoscientifix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:00:58.960313+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}